Theravance Inc (NASDAQ:THRX)

18.06
Delayed Data
As of Feb 27
 -0.03 / -0.17%
Today’s Change
10.58
Today|||52-Week Range
31.80
+27.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-115.3M-18.5M-170.7M--
 
 
 
 
Depreciation7.6M7.3M8.2M--
 
 
 
 
Total Other Cash Flow24.9M24.0M27.1M--
 
 
 
 
Funds From Operations-82.8M12.8M-135.4M--
 
 
 
 
Funds From/For Other Operating Expenses5.5M140.7M-5.8M--
 
 
 
 
Net Cash Flow - Operating Activities-88.3M-128.0M-129.6M--
 
 
 
 
 
InvestingIncrease In Investments-301.6M-330.5M-410.4M--
 
 
 
 
Decrease In Investments248.8M274.6M278.5M--
 
 
 
 
Capital Expenditures-3.6M-2.6M-2.7M--
 
 
 
 
Other Investing - Uses-140.0K-140.0K0.00--
 
 
 
Other Investing - Sources715.0K300.0K100.0K--
 
 
 
 
Net Cash Flow Investing-55.8M-58.3M-219.6M--
 
 
 
 
 
FinancingShort Term Borrowings0.00-69.0K0.00--
 
 
Long Term Borrowings0.000.00281.6M--
 
 
Long Term Debt Reduction-206.0K0.000.00--
 
 
Net Proceeds Stock Sale25.8M236.4M153.0M--
 
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.000.0036.8M--
 
 
Net Cash Flow - Financing25.6M236.3M397.8M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.00----
 
Net Change In Cash-118.6M50.1M48.7M0.00
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account